Related references
Note: Only part of the references are listed.Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms
Johan Frostegard et al.
ARTHRITIS RESEARCH & THERAPY (2021)
PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1
Zufeng Ding et al.
CARDIOVASCULAR RESEARCH (2020)
The enigma of soluble LDLR: could inflammation be the key?
Majambu Mbikay et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data
Julita Anna Krahel et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Relationship of PCSK9 levels with indices of vascular function and subclinical atherosclerosis in patients with familial dyslipidemias
Charalambos Vlachopoulos et al.
HELLENIC JOURNAL OF CARDIOLOGY (2019)
Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients
Federico Diaz-Gonzalez et al.
HORMONE AND METABOLIC RESEARCH (2019)
Emerging role of proprotein convertase subtilisin/kexin type-9 (PCSK-9) in inflammation and diseases
Madalyn Brown et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
PCSK9 and inflammation: a review of experimental and clinical evidence
Amir Abbas Momtazi-Borojeni et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2019)
Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
Aikaterini Arida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Associations Between Soluble LDLR and Lipoproteins in a White Cohort and the Effect of PCSK9 Loss-of-Function
Janice Mayne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials
Ye-Xuan Cao et al.
BMJ OPEN (2018)
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
R. Agca et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway
Zhi-Han Tang et al.
ATHEROSCLEROSIS (2017)
PCSK9 regulates the chemokine receptor CCR2 on monocytes
Jana Grune et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study
Wuxiang Xie et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
Rishi K. Wadhera et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors
Aikaterini Arida et al.
CLINICAL RHEUMATOLOGY (2015)
Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials
A. Sahebkar et al.
DIABETES OBESITY & METABOLISM (2015)
Atherosclerosis in rheumatoid arthritis: is it all about inflammation?
Sarah Skeoch et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Association Between Serum Soluble Low-Density Lipoprotein Receptor Levels and Metabolic Factors in Healthy Japanese Individuals
Hisashi Shimohiro et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2015)
Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox
Miguel A. Gonzalez-Gay et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
PCSK9: A Key Modulator of Cardiovascular Health
Nabil G. Seidah et al.
CIRCULATION RESEARCH (2014)
PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages
Zhihan Tang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Evan A. Stein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis
Jean-Frederic Boyer et al.
JOINT BONE SPINE (2011)
Atherosclerosis in Rheumatoid Arthritis Versus Diabetes A Comparative Study
Kimon S. Stamatelopoulos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Inflammation stimulates the expression of PCSK9
Kenneth R. Feingold et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Soluble LDL-R are formed by cell surface cleavage in response to phorbol esters
MJ Begg et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
